Conatus Pharmaceuticals Q3 EPS $(0.1) Up From $(0.15) YoY, Sales $3.376M Down From $7.666M YoY

Conatus Pharmaceuticals (NASDAQ:CNAT) reported quarterly losses of $(0.1) per share. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported $3.376 million

Benzinga · 11/05/2019 21:13

Conatus Pharmaceuticals (NASDAQ:CNAT) reported quarterly losses of $(0.1) per share. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported $3.376 million in sales this quarter. This is a 55.96 percent decrease over sales of $7.666 million the same period last year.